Symposium：the 65th Annual Meeting of the Japanese Society of Clinical Chemistry

2025.11.07

SCIENCE

Symposium：the 65th Annual Meeting of the Japanese Society of Clinical Chemistry

Provigate Inc. is pleased to announce that our CEO, Koshin Sekimizu, will participate in the 20th Corporate Symposium at the 65th Annual Meeting of the Japanese Society of Clinical Chemistry, to be held from November 7–9, 2025, at WINC AICHI in Nagoya. His presentation is scheduled for Saturday, November 8, from 3:30 p.m.

Conference participation requires registration. For more details, please visit the official website below.
https://square.umin.ac.jp/jscc2025/index.html
We look forward to seeing you there!

Event Name
The 65th Annual Meeting of the Japanese Society of Clinical Chemistry

Symposium Title
The 20th Corporate Symposium: Clinical Chemistry and Industry Forum
“Power of Knowledge to Create the Future: Toward a New Era of Clinical Chemistry through DX and AI”

Date & Venue
November 8 (Sat), 2025　3:30–6:00 p.m.
WINC AICHI
4-4-38 Meieki, Nakamura-ku, Nagoya, Aichi 450-0002, Japan

Symposium Overview
Chairs:
• Mitsuru Miyata (Miyata Research Institute, Inc.)
• Kana Arimoto (System Integration Group, Global Business R&D Division, Beckman Coulter, Inc.)

Speakers:
• Atsushi Oshio (Faculty of Engineering, Reitaku University)
“Next-Generation Medical Systems Driven by AI”
• Koshin Sekimizu (Provigate Inc.)
“New Developments in Diabetes Management through Weekly Home Glycoalbumin Monitoring”
• Masanori Otake (GE Healthcare Japan Corporation)
“Latest Regulatory Trends and Future Directions for AI-Based Medical Devices”

For further information, please visit the official website of the 65th Annual Meeting of the Japanese Society of Clinical Chemistry.
https://square.umin.ac.jp/jscc2025/index.html

People may think of glucose monitoring as simple as this: "Diabetes is a disease of blood sugar. This is why people with diabetes use glucometer."
However, it's not that simple. Blood sugar measurement has diverse objectives, including diagnosing diabetes, dosing self-injection of insulin, avoiding hypoglycemia due to excessive drug efficacy, and behavior change.
You must choose the appropriate blood sugar measurement method for your purpose.

There are two types of self-blood glucose measurement methods: SMBG (Self-Monitoring of Blood Glucose), which is widely used, and CGM (Continuous Glucose Monitoring), which has become popular in recent years.
These two blood glucose measurement methods are designed mainly for patients who self-inject insulin and other injectable drugs.
Until now, there has been no simple and daily method for measuring blood glucose at home other than these two methods.

Some drugs, such as insulin, are very potent and can cause dangerous hypoglycemia if the dosage is incorrect.
Therefore, for example, those who use insulin must measure their blood glucose accurately before self-injection at home and carefully determine the dose.
After injection, if there are signs of hypoglycemia, it is necessary to measure blood glucose immediately. If necessary, you need to take some sugar to avoid hypoglycemia.
However, both methods have an issue with invasiveness. In addition, they cost a lot. CGM costs at least $60 and needs to be replaced every two weeks, which is also a significant economic burden. SMBG requires frequent measurements, so the total cost becomes significant when accumulated.
Unfortunately, SMBG and CGM are not suitable for everyone due to invasiveness and cost.